These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1971588)

  • 1. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    Eur Heart J; 1990 Apr; 11 Suppl A():45. PubMed ID: 1971588
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    J Intern Med; 1989 Nov; 226(5):331-5. PubMed ID: 2572666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris.
    Barrios L; Geboers J; Piessens JH; de Geest H
    Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.
    Cheron P; Nannan M; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():46-7. PubMed ID: 1971589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
    Watanabe K; Hirokawa Y; Shibata A
    J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Furlong R; Brogden RN
    Drugs; 1988 Oct; 36(4):455-74. PubMed ID: 2906865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
    de Feyter PJ; Serruys PW; Suryapranata H
    Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
    Detry JM; Decoster PM; Buy JJ; Rousseau MF; Brasseur LA
    Am J Cardiol; 1984 Feb; 53(4):439-43. PubMed ID: 6141726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
    European 'Corwin' Study Group
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
    van Mechelen H; Ries A; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic and metabolic effects of ICI 118,587 (Corwin), a selective partial beta 1 agonist, in patients with dilated cardiomyopathy.
    Bhatia SJ; Swedberg K; Chatterjee K
    Am Heart J; 1986 Apr; 111(4):692-6. PubMed ID: 2869673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate.
    Gilligan DM; Stewart R; Chan WL; Oakley CM
    Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
    Molajo AO; Bennett DH
    Br Heart J; 1985 Jul; 54(1):17-21. PubMed ID: 2861834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term xamoterol in idiopathic dilated cardiomyopathy.
    Watanabe K; Hirokawa Y; Suzuki K; Masani F; Otsuka H; Shibata A
    Jpn Circ J; 1992 Jan; 56(1):12-20. PubMed ID: 1347090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease.
    Molajo AO; Bennett DH; Marlow HF; Snow HM; Bastain W
    Br J Clin Pharmacol; 1987 Sep; 24(3):373-9. PubMed ID: 2889460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
    Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.